Resolve Therapeutics, LLC is excited to share our latest milestone, and we’re proud of the teams and partners who helped make this happen! 🎉
“Resolve Therapeutics Presents Preclinical Data on NET Degradation and Nuclease Therapy in Acute Ischemic Stroke at the World Stroke Conference”
Check out the announcement and join the conversation:
#Resolve Therapeutics, LLC
Press Release from PR Newswire www.prnewswire.com